CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $709,240
- in 1 filing, $709K under 10b5-1 plans
Net −$709,240. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-05 | FALBERG KATHRYN E Director | Purchase | +43,000 | $1.95 | $84K | 250,000 |
| 2022-12-02 | FALBERG KATHRYN E Director | Purchase | +47,000 | $1.98 | $93K | 207,000 |
| 2022-12-01 | FALBERG KATHRYN E Director | Purchase | +84,959 | $1.97 | $168K | 160,000 |
| 2022-11-30 | FALBERG KATHRYN E Director | Purchase | +75,041 | $1.85 | $139K | 75,041 |
| 2022-08-29 | Wentworth Kerry Chief Regulatory Officer | Grant or award · Stock Option (Right to Buy) | +252,000 | 252,000 | ||
| 2022-08-29 | Markel Stacy Chief People Officer | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 | ||
| 2022-08-29 | Liu Dongfang Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +315,000 | 315,000 | ||
| 2022-08-29 | Hattersley Gary Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2022-08-29 | Hanley David C. Chief Technical Operations | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 | ||
| 2022-08-29 | Fox Jennifer A. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +480,000 | 480,000 | ||
| 2022-07-15 | Liu Dongfang Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +490,000 | 490,000 | ||
| 2022-07-15 | Liu Dongfang Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +292,500 | 292,500 | ||
| 2022-05-23 | Wentworth Kerry Chief Regulatory Officer | Grant or award · Stock Option (Right to Buy) | +330,000 | 330,000 | ||
| 2022-05-23 | Wentworth Kerry Chief Regulatory Officer | Grant or award · Stock Option (Right to Buy) | +247,500 | 247,500 | ||
| 2022-05-16 | WELCH DANIEL G Director | Grant or award · Stock Option (Right to Buy) | +140,713 | 140,713 | ||
| 2022-05-16 | VERNON W ANTHONY Director | Grant or award · Stock Option (Right to Buy) | +140,713 | 140,713 | ||
| 2022-05-16 | FALBERG KATHRYN E Director | Grant or award · Stock Option (Right to Buy) | +140,713 | 140,713 | ||
| 2022-05-16 | BLICKENSTAFF KIM D Director | Grant or award · Stock Option (Right to Buy) | +140,713 | 140,713 | ||
| 2022-05-16 | Bazemore Robert B Director | Grant or award · Stock Option (Right to Buy) | +140,713 | 140,713 | ||
| 2022-05-16 | Bazemore Robert B Director | Grant or award · Stock Option (Right to Buy) | +118,784 | 118,784 |
Page 10 of 15 · 291 trades